Title : Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts.

Pub. Date : 2005 Apr

PMID : 15771957






7 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts. Depsipeptides TNF superfamily member 10 Homo sapiens
2 Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts. Depsipeptides TNF superfamily member 10 Homo sapiens
3 Thus, studies were initiated to evaluate the ability of depsipeptide to enhance the cytotoxic activity of Ad5-TRAIL against human prostate tumor cells. Depsipeptides TNF superfamily member 10 Homo sapiens
4 Additionally, tumor cell killing by Ad5-TRAIL was higher following depsipeptide pretreatment. Depsipeptides TNF superfamily member 10 Homo sapiens
5 Investigation into the mechanism responsible for increased TRAIL responsiveness revealed increased levels of TRAIL-R1 and -R2 in membrane lipid rafts following depsipeptide treatment. Depsipeptides TNF superfamily member 10 Homo sapiens
6 These results indicate that depsipeptide is a potent agent for enhancing the activity of Ad5-TRAIL by multiple mechanisms, allowing for a more efficient use of Ad5-TRAIL as an antitumor therapy. Depsipeptides TNF superfamily member 10 Homo sapiens
7 These results indicate that depsipeptide is a potent agent for enhancing the activity of Ad5-TRAIL by multiple mechanisms, allowing for a more efficient use of Ad5-TRAIL as an antitumor therapy. Depsipeptides TNF superfamily member 10 Homo sapiens